Phase II study of erlotinib monotherapy versus in erlotinib in combination with nab-paclitaxel, in patients with epidermal growth factor receptor wild-type non-small-cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2015
At a glance
- Drugs Paclitaxel (Primary) ; Erlotinib
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Sep 2015 New trial record